Skip to main content

Birchview Capital, LP

Position in NBIX — Neurocrine Biosciences Inc

CIK 1618205 BURLINGTON, VT

Position in NBIX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,582,602
+$1,000,592 QoQ
Shares Held
27,190
0.0% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
2.16%
of 13F equity value
Holder Rank
#225
of 768 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Birchview Capital, LP holds $12,354,557 across 5 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (37.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
This page
27,190 $4,582,602

All Filings in NBIX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,582,602 27,190
2026-03-31 $3,582,010 27,190
2025-12-31 $3,856,357 27,190
2025-09-30 $4,027,502 28,690
2025-06-30 $3,888,848 30,940
2025-03-31 $3,344,544 30,240
2024-12-31 $4,127,760 30,240
2024-09-30 $3,484,252 30,240
2024-06-30 $5,815,180 42,240
2024-03-31 $10,652,940 77,240
2023-12-31 $10,177,142 77,240
2023-09-30 $8,689,500 77,240
2023-06-30 $7,943,832 84,240
2023-03-31 $8,526,772 84,240
2022-12-31 $10,061,625 84,240
2022-09-30 $9,053,340 85,240
2022-06-30 $8,309,195 85,240
2022-03-31 $8,366,250 89,240
2021-12-31 $7,597,164 89,200
2021-09-30 $7,691,982 80,200
2021-06-30 $7,805,064 80,200
2021-03-31 $7,799,450 80,200
2020-12-31 $7,687,170 80,200
2020-09-30 $7,500,480 78,000
2020-06-30 $9,516,000 78,000
2020-03-31 $6,404,700 74,000